Hikma Pharma (HKMPF) Stock Price, News & Analysis
Company Description
Hikma Pharma (OTC Link: HKMPF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $5.1B.
HKMPF has declined 24.0% over the past year. Shares last traded at $21.25.
This page collects what Stock Titan holds for HKMPF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Hikma Pharma (HKMPF) stock last closed at $21.25. Over the past 12 months, the stock has lost 24.0%. At a market capitalization of $5.1B, HKMPF is classified as a mid-cap stock with approximately 221.5M shares outstanding.
Latest News
Hikma Pharma has 9 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include fda approval, partnership. View all HKMPF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Hikma Pharma (HKMPF) currently stands at 148.2 thousand shares, up 1.2% from the previous reporting period, representing 0.1% of the float. Since July 2025, short interest has decreased by 51.6%. This relatively low short interest suggests limited bearish sentiment. With 86.1 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Hikma Pharma (HKMPF) currently stands at 86.1 days, down 56.2% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 91.4% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 38.5 to 1000.0 days.
HKMPF Company Profile & Sector Positioning
Hikma Pharma (HKMPF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing HKMPF often look at related companies in the same sector, including Hikma Pharmaceuticals Plc (HKMPY), Procaps Group Sa (PROCF), Almirall (LBTSF), Almirall SA (ALMRY), and Hypera Sa (HYPMY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HKMPF's relative position within its industry.